Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Green Tea Saves the Brain in Stroke

By HospiMedica staff writers
Posted on 09 Feb 2007
A basic compound found in every cell in the body and in an extract of green tea may prevent brain damage caused from stroke, according to two new studies.

In the first study, researchers at the San Francisco Veterans' Affairs (VA) Medical Center (SFVAMC, CA, USA) subjected rats' brains to ischemia for two hours in a model of stroke. More...
The researchers then administered nicotinamide adenine dinucleotide (NAD+) intranasally immediately after reperfusion (the time when stroke damage actually occurs, since brain cells are suddenly exposed to highly reactive, toxic, and unstable oxygen molecules). The researchers found that NAD+ reduced brain cell death from reperfusion by 70-86% compared with rats not given the treatment. The study was published in the January 1, 2007, issue of Frontiers in Bioscience.

NAD+ plays a number of essential roles in cell metabolism. One role is supporting the activity of the DNA repair enzyme poly (adenosine diphosphate-ribose) polymerase (PARP-1), which normally repairs cell damage from brain infection. In response to reperfusion following ischemia or brain trauma, PARP-1 is overactivated, quickly depleting all available NAD+, and is consequently unable to repair cell damage, leading to brain cell death.

In the second study, by the same team of researchers, green tea extract gallotannin (GT) showed similar results to NAD+, reducing brain cell death significantly when administered intranasally up to three hours after reperfusion. GT has been shown to inhibit the action of the enzyme poly (adenosine diphosphate-ribose) glycohydrolase (PARG) - an enzyme closely related to PARP-1 - and in doing so decrease cell death under ischemia-like conditions. The study also showed that GT provided no protection at all against either PARG or apoptosis inducing factor (AIF) when administered intravenously (IV). The results of the study were reported at the 2006 annual meeting of the American Society for Neurosciences, held in Atlanta (GA, USA) during October 2006.

Our experimental results have suggested that NAD+ can produce greater protective effects than GT against ischemia,” said lead author of both studies Weihei Ying, Ph.D., a research scientist at SFVAMC and an assistant adjunct professor of neurology at the University of California, San Francisco (UCSF, USA). "Plus, NAD+ is a fundamental molecule for cell metabolism, so it is known to have relatively low toxicity.”



Related Links:
San Francisco veterans affairs (VA) Medical Center
University of California, San Francisco

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.